Levodopa News and Research

RSS
UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

UAB researchers uncover vital mechanism for L-DOPA-induced-dyskinesia

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

Leukemia drug increases brain dopamine, lowers toxic proteins linked to Parkinson's or dementia

Transplantation of hpNSCs into non-human primates modeled with PD promotes behavioral recovery

Transplantation of hpNSCs into non-human primates modeled with PD promotes behavioral recovery

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

NeuroDerm starts patient enrollment in long-term safety study of ND0612 for treatment of Parkinson’s disease

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

New clinical trial focuses on respiratory drug ambroxol for treatment of Parkinson's disease

Aerobic exercise training may slow progression of Parkinson's disease

Aerobic exercise training may slow progression of Parkinson's disease

Weight loss may mark rapid Parkinson’s disease progression

Weight loss may mark rapid Parkinson’s disease progression

Opicapone simplifies levodopa-related motor fluctuation treatment

Opicapone simplifies levodopa-related motor fluctuation treatment

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

Impax's NUMIENT granted EC marketing authorization for symptomatic treatment of adult patients with Parkinson's disease

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

SynAgile announces positive results from Phase 2a trial of continuous intraoral LD/CD therapy

Olfactory function may inform Parkinson’s prognosis

Olfactory function may inform Parkinson’s prognosis

Study reveals why long-term use of L-DOPA leads to dyskinesia

Study reveals why long-term use of L-DOPA leads to dyskinesia

University of Maryland Medicine offers MRI-guided focused ultrasound treatment to Parkinson's patients

University of Maryland Medicine offers MRI-guided focused ultrasound treatment to Parkinson's patients

IQWiG finds no added benefit for safinamide in Parkinson disease

IQWiG finds no added benefit for safinamide in Parkinson disease

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk

Putaminal serotonergic innervation flags levodopa-induced dyskinesia risk

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

Low-dose lithium lowers involuntary motor movements in mouse model of Parkinson's disease

Severe dyskinesias rare in community Parkinson’s cohort

Severe dyskinesias rare in community Parkinson’s cohort

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

Pharma Two B reports positive results from P2B001 Phase IIb study for treatment of early stage PD

Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Health Canada informs Canadians that eight unauthorized health products were seized from Better Bodies Supplements

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients

Clinical studies confirm safety, efficacy of opicapone in Parkinson’s disease patients